Royalty Pharma Plc Free Cash Flow Generation Index
Royalty Pharma Plc free cash flow generation index. Royalty Pharma Plc (RPRX) has a Free Cash Flow Generation Index of 1.00x as of March 2026. Free cash flow of $760.54 Million represents 1% of operating cash flow ($760.54 Million). Check asset resilience ratio of Royalty Pharma Plc to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Royalty Pharma Plc (2002–2025)
Free cash flow generation index of Royalty Pharma Plc from 2002 to 2025. Historical FCF Generation Index trend for Royalty Pharma Plc across 11 annual periods. Explore capital reinvestment ratio of Royalty Pharma Plc to see what proportion of operating cash flow is directed to capital expenditures.
Royalty Pharma Plc Free Cash Flow Generation Index by Year (2002–2025)
Royalty Pharma Plc free cash flow generation index by year from 2002 to 2025. Year-by-year Free Cash Flow Generation Index for Royalty Pharma Plc. For the full cash flow conversion analysis, see RPRX operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | $2.49 Billion | $2.49 Billion | $0.00 | ▲ +0.0% |
| 2024 | 1.00x | $2.77 Billion | $2.77 Billion | $0.00 | ▲ +0.0% |
| 2023 | 1.00x | $2.99 Billion | $2.99 Billion | $2.12 Billion | ▼ -48.8% |
| 2022 | 1.95x | $4.19 Billion | $2.14 Billion | $2.04 Billion | ▲ +95.2% |
| 2021 | 1.00x | $2.02 Billion | $2.02 Billion | $523.00K | ▼ -51.9% |
| 2020 | 2.08x | $4.23 Billion | $2.03 Billion | $2.20 Billion | ▲ +108.0% |
| 2019 | 1.00x | $1.67 Billion | $1.67 Billion | $1.72 Billion | ▲ +0.0% |
| 2018 | 1.00x | $1.62 Billion | $1.62 Billion | $269.59 Million | ▲ +0.0% |
| 2017 | 1.00x | $1.42 Billion | $1.42 Billion | $2.29 Billion | ▲ +0.0% |
| 2003 | 1.00x | $11.15 Million | $11.15 Million | $0.00 | ▼ -0.6% |
| 2002 | 1.01x | $8.49 Million | $8.45 Million | $49.00K | — |